Page de couverture de Beatriz Grinsztejn on Lenacapavir and the future of HIV prevention

Beatriz Grinsztejn on Lenacapavir and the future of HIV prevention

Beatriz Grinsztejn on Lenacapavir and the future of HIV prevention

Écouter gratuitement

Voir les détails du balado

À propos de cet audio

In this episode, our editor-in-chief Taissa Vila sits down with Dr. Beatriz Grinsztejn to discuss the challenges of expanding access to pre-exposure prophylaxis (PrEP), with a focus on issues of adherence and equity in Latin America.

We explore the potential of Lenacapavir as a game-changing intervention, reflect on lessons learned from previous experiences with injectable PrEP, and examine the critical importance of introducing new prevention tools through an equity-based approach.

Finally, we look ahead to what Lenacapavir could mean for the future of HIV prevention strategies worldwide. Tune in for an insightful conversation on how innovative strategies like Lenacapavir could reshape the future of HIV awareness and prevention.

Read the full article:

https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(25)00156-5/fulltext?dgcid=buzzsprout_icw_podcast_July_25_laname

Ce que les auditeurs disent de Beatriz Grinsztejn on Lenacapavir and the future of HIV prevention

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.